
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunomodulation by radiotherapy in tumour control and normal tissue toxicity
Urszula Cytlak, Douglas P. Dyer, Jamie Honeychurch, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 2, pp. 124-138
Open Access | Times Cited: 160
Urszula Cytlak, Douglas P. Dyer, Jamie Honeychurch, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 2, pp. 124-138
Open Access | Times Cited: 160
Showing 1-25 of 160 citing articles:
Emerging evidence for adapting radiotherapy to immunotherapy
Lorenzo Galluzzi, Molykutty J. Aryankalayil, C. Norman Coleman, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 543-557
Closed Access | Times Cited: 161
Lorenzo Galluzzi, Molykutty J. Aryankalayil, C. Norman Coleman, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 543-557
Closed Access | Times Cited: 161
Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma
Rui Xing, Jinping Gao, Qi Cui, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 125
Rui Xing, Jinping Gao, Qi Cui, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 125
NK cells and solid tumors: therapeutic potential and persisting obstacles
Le Tong, Carlos Jiménez‐Cortegana, Apple H.M. Tay, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 96
Le Tong, Carlos Jiménez‐Cortegana, Apple H.M. Tay, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 96
Targeting immunogenic cell stress and death for cancer therapy
Lorenzo Galluzzi, Emma Guilbaud, Darby Schmidt, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 6, pp. 445-460
Open Access | Times Cited: 76
Lorenzo Galluzzi, Emma Guilbaud, Darby Schmidt, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 6, pp. 445-460
Open Access | Times Cited: 76
Engineered Living Materials for Advanced Diseases Therapy
Dong Xue, Wei Wu, Pei Pan, et al.
Advanced Materials (2023)
Closed Access | Times Cited: 49
Dong Xue, Wei Wu, Pei Pan, et al.
Advanced Materials (2023)
Closed Access | Times Cited: 49
A Metal–Phenolic Nanocoordinator Launches Radiotherapeutic Cancer Pyroptosis Through an Epigenetic Mechanism
Guohao Wang, Bei Li, Hao Tian, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 23
Closed Access | Times Cited: 48
Guohao Wang, Bei Li, Hao Tian, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 23
Closed Access | Times Cited: 48
Cancer cell metabolism and antitumour immunity
Mara De Martino, Jeffrey C. Rathmell, Lorenzo Galluzzi, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 9, pp. 654-669
Open Access | Times Cited: 44
Mara De Martino, Jeffrey C. Rathmell, Lorenzo Galluzzi, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 9, pp. 654-669
Open Access | Times Cited: 44
Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer
Lenka Kašíková, Jana Raková, Michal Hensler, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 29
Lenka Kašíková, Jana Raková, Michal Hensler, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 29
Oxygen‐driven cuproptosis synergizes with radiotherapy to potentiate tumor immunotherapy
Pei Pei, Yuhong Wang, Wenhao Shen, et al.
Aggregate (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 27
Pei Pei, Yuhong Wang, Wenhao Shen, et al.
Aggregate (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 27
Recent advances in the metal/organic hybrid nanomaterials for cancer theranostics
Zhaoyi Ye, Ying Bao, Zefeng Chen, et al.
Coordination Chemistry Reviews (2024) Vol. 504, pp. 215654-215654
Closed Access | Times Cited: 18
Zhaoyi Ye, Ying Bao, Zefeng Chen, et al.
Coordination Chemistry Reviews (2024) Vol. 504, pp. 215654-215654
Closed Access | Times Cited: 18
Mitochondria Energy Metabolism Depression as Novel Adjuvant to Sensitize Radiotherapy and Inhibit Radiation Induced‐Pulmonary Fibrosis
Zaigang Zhou, Xin Jiang, Yi Lei, et al.
Advanced Science (2024) Vol. 11, Iss. 26
Open Access | Times Cited: 17
Zaigang Zhou, Xin Jiang, Yi Lei, et al.
Advanced Science (2024) Vol. 11, Iss. 26
Open Access | Times Cited: 17
Radiopharmaceuticals and their applications in medicine
Siqi Zhang, Xingkai Wang, Xin Gao, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Siqi Zhang, Xingkai Wang, Xin Gao, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Chemical Design of Magnetic Nanomaterials for Imaging and Ferroptosis-Based Cancer Therapy
Wei Xu, Guoqiang Guan, Renye Yue, et al.
Chemical Reviews (2025)
Closed Access | Times Cited: 4
Wei Xu, Guoqiang Guan, Renye Yue, et al.
Chemical Reviews (2025)
Closed Access | Times Cited: 4
When cell death goes wrong: inflammatory outcomes of failed apoptosis and mitotic cell death
Florian J. Bock, Joel S. Riley
Cell Death and Differentiation (2022) Vol. 30, Iss. 2, pp. 293-303
Open Access | Times Cited: 45
Florian J. Bock, Joel S. Riley
Cell Death and Differentiation (2022) Vol. 30, Iss. 2, pp. 293-303
Open Access | Times Cited: 45
Precise Engineering of a Se/Te Nanochaperone for Reinvigorating Cancer Radio‐Immunotherapy
Yanzhou Chang, Jia‐Run Huang, Sujiang Shi, et al.
Advanced Materials (2023) Vol. 35, Iss. 36
Closed Access | Times Cited: 27
Yanzhou Chang, Jia‐Run Huang, Sujiang Shi, et al.
Advanced Materials (2023) Vol. 35, Iss. 36
Closed Access | Times Cited: 27
Targeting STING Activation by Antigen‐Inspired MnO2 Nanovaccines Optimizes Tumor Radiotherapy
Yuan Gu, Subin Lin, Yanxian Wu, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 12
Closed Access | Times Cited: 26
Yuan Gu, Subin Lin, Yanxian Wu, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 12
Closed Access | Times Cited: 26
Baseline gut microbiota composition is associated with oral mucositis and tumour recurrence in patients with head and neck cancer: a pilot study
Ghanyah Al-Qadami, Joanne M. Bowen, Ysabella Van Sebille, et al.
Supportive Care in Cancer (2023) Vol. 31, Iss. 1
Open Access | Times Cited: 22
Ghanyah Al-Qadami, Joanne M. Bowen, Ysabella Van Sebille, et al.
Supportive Care in Cancer (2023) Vol. 31, Iss. 1
Open Access | Times Cited: 22
Application of bismuth sulfide based nanomaterials in cancer diagnosis and treatment
Zhongwei Yang, Longwei Wang, Jian Zhang, et al.
Nano Today (2023) Vol. 49, pp. 101799-101799
Closed Access | Times Cited: 22
Zhongwei Yang, Longwei Wang, Jian Zhang, et al.
Nano Today (2023) Vol. 49, pp. 101799-101799
Closed Access | Times Cited: 22
Deciphering the fibrotic process: mechanism of chronic radiation skin injury fibrosis
Yiren Wang, Shouying Chen, Shuilan Bao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Yiren Wang, Shouying Chen, Shuilan Bao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Radioresponsive Delivery of Toll-like Receptor 7/8 Agonist for Tumor Radioimmunotherapy Enabled by Core-Cross-Linked Diselenide Nanoparticles
Yanxian Wu, Jianzhong Qin, Yuan Gu, et al.
ACS Nano (2024) Vol. 18, Iss. 4, pp. 2800-2814
Closed Access | Times Cited: 9
Yanxian Wu, Jianzhong Qin, Yuan Gu, et al.
ACS Nano (2024) Vol. 18, Iss. 4, pp. 2800-2814
Closed Access | Times Cited: 9
Atomically precise Ag clusters for intelligent NIR-II imaging
Huizhen Ma, Ling Liu, Hua He, et al.
Matter (2024) Vol. 7, Iss. 4, pp. 1660-1676
Closed Access | Times Cited: 9
Huizhen Ma, Ling Liu, Hua He, et al.
Matter (2024) Vol. 7, Iss. 4, pp. 1660-1676
Closed Access | Times Cited: 9
Advanced Polymeric Nanoparticles for Cancer Immunotherapy: Materials Engineering, Immunotherapeutic Mechanism and Clinical Translation
Wencong Jia, Ye Wu, Yujie Xie, et al.
Advanced Materials (2025)
Closed Access | Times Cited: 1
Wencong Jia, Ye Wu, Yujie Xie, et al.
Advanced Materials (2025)
Closed Access | Times Cited: 1
Co-activating STING-TLR9 pathways promotes radiotherapy-induced cancer vaccination
Yuling Sun, Liang Liu, Huilan He, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 327-343
Closed Access | Times Cited: 1
Yuling Sun, Liang Liu, Huilan He, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 327-343
Closed Access | Times Cited: 1
CD73/adenosine dynamics in treatment-induced pneumonitis: balancing efficacy with risks of adverse events in combined radio-immunotherapies
Lena Gockeln, Florian Wirsdörfer, Verena Jendrossek
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 1
Lena Gockeln, Florian Wirsdörfer, Verena Jendrossek
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 1
Anaerobic Probiotics-in situ Se nanoradiosensitizers Selectively Anchor to Tumor with Immuno-regulations for Robust Cancer Radio-immunotherapy
Yangyang Yu, Ying Wang, Jilei Zhang, et al.
Biomaterials (2025) Vol. 318, pp. 123117-123117
Closed Access | Times Cited: 1
Yangyang Yu, Ying Wang, Jilei Zhang, et al.
Biomaterials (2025) Vol. 318, pp. 123117-123117
Closed Access | Times Cited: 1